These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32445622)

  • 21. Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study.
    Patel SK; Restrepo C; Werden E; Churilov L; Ekinci EI; Srivastava PM; Ramchand J; Wai B; Chambers B; O'Callaghan CJ; Darby D; Hachinski V; Cumming T; Donnan G; Burrell LM; Brodtmann A
    BMC Endocr Disord; 2017 Apr; 17(1):24. PubMed ID: 28388897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Exercise on Type 2 Diabetes Mellitus-Related Cognitive Impairment and Dementia.
    Callisaya M; Nosaka K
    J Alzheimers Dis; 2017; 59(2):503-513. PubMed ID: 28598841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers.
    Maeba R; Araki A; Fujiwara Y
    Adv Clin Chem; 2018; 87():69-111. PubMed ID: 30342713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 2 diabetes mellitus and biomarkers of neurodegeneration.
    Moran C; Beare R; Phan TG; Bruce DG; Callisaya ML; Srikanth V;
    Neurology; 2015 Sep; 85(13):1123-30. PubMed ID: 26333802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression, Type 2 Diabetes, and Poststroke Cognitive Impairment.
    Swardfager W; MacIntosh BJ
    Neurorehabil Neural Repair; 2017 Jan; 31(1):48-55. PubMed ID: 27364648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia.
    Strachan MW
    Diabet Med; 2011 Feb; 28(2):141-7. PubMed ID: 21219420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms.
    Alosco ML; Gunstad J
    Curr Diab Rep; 2014 Jun; 14(6):495. PubMed ID: 24752836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective.
    Simó R; Ciudin A; Simó-Servat O; Hernández C
    Acta Diabetol; 2017 May; 54(5):417-424. PubMed ID: 28210868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
    Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH
    Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive impairment in type 2 diabetes mellitus.
    Karvani M; Simos P; Stavrakaki S; Kapoukranidou D
    Hormones (Athens); 2019 Dec; 18(4):523-534. PubMed ID: 31522366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression.
    van Sloten TT; Sedaghat S; Carnethon MR; Launer LJ; Stehouwer CDA
    Lancet Diabetes Endocrinol; 2020 Apr; 8(4):325-336. PubMed ID: 32135131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes and Cognitive Impairment.
    Zilliox LA; Chadrasekaran K; Kwan JY; Russell JW
    Curr Diab Rep; 2016 Sep; 16(9):87. PubMed ID: 27491830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A promising structural magnetic resonance imaging assessment in patients with preclinical cognitive decline and diabetes mellitus.
    Dong Y; Wang Q; Yao H; Xiao Y; Wei J; Xie P; Hu J; Chen W; Tang Y; Zhou H; Liu J
    J Cell Physiol; 2019 Aug; 234(10):16838-16846. PubMed ID: 30786010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain microstructural abnormalities in type 2 diabetes mellitus: A systematic review of diffusion tensor imaging studies.
    Sanjari Moghaddam H; Ghazi Sherbaf F; Aarabi MH
    Front Neuroendocrinol; 2019 Oct; 55():100782. PubMed ID: 31401292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.
    Ren QG; Chang JH; Lu WJ; Gong WG; Zhou H
    Neurol Sci; 2017 Sep; 38(9):1691-1696. PubMed ID: 28681311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal magnetic resonance imaging study of neurodegenerative and small vessel disease, and clinical cognitive trajectories in non demented patients with transient ischemic attack: the PREVENT study.
    Tariq S; d'Esterre CD; Sajobi TT; Smith EE; Longman RS; Frayne R; Coutts SB; Forkert ND; Barber PA
    BMC Geriatr; 2018 Jul; 18(1):163. PubMed ID: 30012102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.